PRFUF yields 80000.00% · PFE yields 6.13%● Live data
📍 PRFUF pulled ahead of the other in Year 1
Combined, PRFUF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PRFUF + PFE for your $10,000?
Prosperous Future Holdings Limited, an investment holding company, manufactures and sells personal care products in the People's Republic of China, Hong Kong, the United States, the United Kingdom, and internationally. It operates through Personal Care Products, Food and Beverage, Financial business, Properties Holding, and Others segments. The company manufactures and sells skin care, body, and hair care products; offers frozen food and beverage products, including meat and poultry; provides frozen warehouse services; and asset management, data analysis, and securities advisory services, as well as deals in securities and futures contracts. In addition, it invests in listed securities and private unlisted funds; offers money lending, finance lease, and factoring services; and provides professional services, such as fund setup and administration, legal and tax consultancy and co-ordination, corporate and accounting, and trust and fiduciary services. Further, the company develops and leases properties; and provides temperature-controlled storage and ancillary services, as well as engages in trading, money lending, and finance lease services. Prosperous Future Holdings Limited was formerly known as Future Development Holdings Limited and changed its name to Prosperous Future Holdings Limited in September 2019. The company was incorporated in 2011 and is headquartered in Central, Hong Kong.
Full PRFUF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.